Literature DB >> 1105671

Laboratory tests for diagnosis of autoimmune diseases.

R M Nakamura, F V Chisari, T S Edgington.   

Abstract

1. Antimitochondrial antibody titers of 1:160 are practically diagnostic of primary biliary cirrhosis [71]. Serum antimitochondrial antibody titers of less than 1:16 are seen in 10% of cases of primary biliary cirrhosis. The antimitochondrial antibodies are usually absent in jaundiced patients with extrahepatic obstruction, drug sensitivity, and viral hepatitis. 2. Anti-smooth-muscle antibodies are noted in the various autoimmune liver disorders, viral hepatitis, infectious mononucleosis, malignancy, and intrinsic bronchial asthma. The smooth muscle antibody test helps in the differential diagnosis of lupoid hepatitis vs. systemic lupus erythematosus. The anti-smooth-muscle antibodies are usually absent in systemic lupus erythematosus. 3. The antinuclear antibody is frequently positive in the autoimmune liver diseases. In cases of chronic aggressive hepatitis associated with a high titer of antinuclear antibody the prognosis is usually grave. 4. The presence of antimicrosomal liver and kidney antibody is indicative of chronic aggressive liver disease, which is different from the classic lupoid hepatitis [95, 97]. 5. Hepatitis-B-antigen assay should be performed routinely to exclude viral hepatitis, type B. Heterophile antibody tests should done when the possibility of infectious mononucleosis must be considered. 6. Serum immunoglobulin determinations are of secondary importance in the laboratory diagnosis of autoimmune liver disorders. There is usually a polyclonal elevation of the major immunoglobulin in most chronic parenchymal liver diseases[48].

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1105671

Source DB:  PubMed          Journal:  Prog Clin Pathol        ISSN: 0079-6174


  5 in total

1.  Performance characteristics of the PolyTiter Immunofluorescent Titration system for determination of antinuclear antibody endpoint dilution.

Authors:  Karen A Flessland; Helen R Landicho; Kimberlee K Borden; Harry E Prince
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Comparison of ANA endpoint dilution using the PolyTiter immunofluorescent titration system and conventional serial dilution.

Authors:  Nicola Bizzaro; Kimberlee K Borden; Karen A Flessland
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

Review 3.  Mycobacterium.

Authors:  L Barksdale; K S Kim
Journal:  Bacteriol Rev       Date:  1977-03

4.  Tumor therapy of neoplastic diseases with tumor cells and neuraminidase. Further experimental studies on chessboard vaccination in canine mammary tumors.

Authors:  H H Sedlacek; G Hagmayer; F R Seiler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Anti-smooth muscle antibodies and liver enzymes in differentiation of extrahepatic biliary atresia and idiopathic neonatal hepatitis: Concern in laboratory medicine view.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Afr J Paediatr Surg       Date:  2017 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.